Clinical trialNCT07516132RecruitingPhase 3Interventional

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

SponsorOcular Therapeutix, Inc.Enrollment850Neovascular Age-Related Macular Degeneration (nAMD)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dilsher Dhoot, MD
California Retina Consultants (CRC)-Bakersfield
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

California Retina Consultants (crc)
Bakersfield, California, United States
Dilsher Dhoot, MD
Recruiting
California Retina Consultants (crc)
Santa Barbara, California, United States
Recruiting
Retina Group of New England
Waterford, Connecticut, United States
Nauman A Chaudhry, MD
Recruiting
Retina Group of Florida - Fort Lauderdale
Fort Lauderdale, Florida, United States
Eduardo Uchiyama, MD
Recruiting
Cumberland Valley Retina Associates
Hagerstown, Maryland, United States
Allen Hu, MD
Recruiting
Mid Atlantic Retina Specialists
Hagerstown, Maryland, United States
Adam Gerstenblith, MD
Recruiting
Palmetto Retina Center
West Columbia, South Carolina, United States
Nitin Nigam, MD
Recruiting
Austin Retina Associates
Austin, Texas, United States
Robert William Wong, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Apr 2026
Primary completion: 1 Aug 2030
Completion: 1 Aug 2030
Last update posted: 1 Jul 2026
Registered enrollment: 850
Registry id: NCT07516132

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.